Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > AL Providers

Dr. Michael W. Meshad, MD

(Dr. Michael Wallace Meshad, MD)

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

University of Alabama at Birmingham School of Medicine (1972)

29653 Anchor Cross Boulevard
Daphne, AL 36526

(251) 625-6513

Dr. Michael W. Meshad, MD is a medical oncologist in Daphne, AL specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Alabama at Birmingham School of Medicine in 1972 and has 54 years of experience. Dr. Michael W. Meshad, MD is affiliated with Infirmary Health, Baldwin Health, Mobile Infirmary and SOUTHERN CANCER CENTER PC.

Office Locations

Baldwin Health

29653 Anchor Cross Boulevard
Daphne, AL 36526

(251) 625-6513

(251) 621-9317

open_in_new

Mobile Infirmary

3 Mobile Infirmary Circle Suite 302
Mobile, AL 36607

(251) 625-6896

(251) 607-5402

open_in_new

3719 Dauphin Street 5th Floor
Mobile, AL 36608

(251) 625-6896

(251) 625-6897

open_in_new

6701 Airport Boulevard B Building, T Level
Mobile, AL 36608

open_in_new

In The News

“It was scheduled for the next day with an oncologist, Dr. Michael Meshad, in nearby Mobile, Ala. "We went home and we sat on our front porch,"Reynolds recalled.”—"A perfect match: How a bone-marrow donation by a Blues fan saved the life of an Alabama teen", New York Times, December 2018

“"Southern Cancer Center is proud to offer an advanced clinical research team that works closely with the National Cancer Institute, US Oncology Research and the pharmaceutical industry to explore...”—"Southern Cancer Center is global leader in kidney cancer clinical trial", Al.com, September 2017

“"We re in negotiations, probably 90 to 95 percent there," said Dr. Michael Meshad, an oncologist with Southern Cancer Center.”—"Southern Cancer Center negotiating merger with Mitchell Cancer Institute", Al.com, April 2011

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2012 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

aspiration	15
biological response modifier (BRM) therapy	625
blood draw	1208
bone marrow tests	30
chemotherapy	625
diagnostic procedures	30
doctor visit	1587
hormone therapy	99
hospital care	388
inpatient care	388
lab tests	3841
minimally invasive procedures	724
port flush	94
preventive care	11
vaccines	11

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2013 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

biological response modifier (BRM) therapy	639
blood draw	1182
chemotherapy	639
doctor visit	1528
hormone therapy	133
hospital care	266
inpatient care	266
lab tests	4153
minimally invasive procedures	664
port flush	54
preventive care	17
vaccines	17

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	285
Female	461

**Ethnicity**
Non-Hispanic White	626
Black	105
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	316
From 75 to 84	274
85 and over	81
Less than 65	75

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2013

Hypertension	69
High Cholesterol	50
Stroke	7
Ischemic Heart Disease	37
Depression	12
Chronic Kidney Disease	24
Asthma	7
Osteoperosis	9
Atrial Fibrilation	13
Heart Failure	21
Chronic Obstructive Pulmonary Disease	16
Diabetes	26
Dementia	12
Cancer	56

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2014 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

biological response modifier (BRM) therapy	484
blood draw	1200
chemotherapy	484
doctor visit	1368
hormone therapy	77
hospital care	262
inpatient care	262
lab tests	4117
minimally invasive procedures	550
port flush	33
preventive care	25
vaccines	25

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	281
Female	433

**Ethnicity**
Non-Hispanic White	595
Black	107
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	311
From 75 to 84	245
85 and over	78
Less than 65	80

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2014

Hypertension	68
High Cholesterol	50
Stroke	7
Ischemic Heart Disease	40
Depression	16
Chronic Kidney Disease	26
Asthma	6
Osteoperosis	8
Atrial Fibrilation	14
Heart Failure	21
Chronic Obstructive Pulmonary Disease	16
Diabetes	27
Dementia	11
Cancer	57

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2015 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

aspiration	20
biological response modifier (BRM) therapy	528
blood draw	1309
bone marrow tests	40
chemotherapy	528
diagnostic procedures	40
doctor visit	1440
hormone therapy	120
hospital care	220
inpatient care	220
lab tests	4311
minimally invasive procedures	612
port flush	45
preventive care	12
vaccines	12

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	572
Female	880

**Ethnicity**
Non-Hispanic White	1200
Black	222
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	664
From 75 to 84	446
85 and over	186
Less than 65	156

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2015

Hypertension	71
High Cholesterol	53
Stroke	6
Ischemic Heart Disease	39
Depression	17
Chronic Kidney Disease	31
Asthma	14
Osteoperosis	9
Atrial Fibrilation	15
Heart Failure	22
Chronic Obstructive Pulmonary Disease	19
Diabetes	28
Dementia	12
Cancer	54

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2016 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

biological response modifier (BRM) therapy	576
blood draw	1367
chemotherapy	576
doctor visit	1448
hormone therapy	94
hospital care	235
inpatient care	235
lab tests	4046
minimally invasive procedures	634
port flush	41
preventive care	11
vaccines	11

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	310
Female	475

**Ethnicity**
Non-Hispanic White	647
Black	120
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	365
From 75 to 84	267
85 and over	73
Less than 65	80

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2016

Hypertension	72
High Cholesterol	53
Stroke	5
Ischemic Heart Disease	38
Depression	15
Chronic Kidney Disease	34
Asthma	21
Osteoperosis	8
Atrial Fibrilation	15
Heart Failure	21
Chronic Obstructive Pulmonary Disease	19
Diabetes	30
Dementia	9
Cancer	57

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2017 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

aspiration	16
biological response modifier (BRM) therapy	514
blood draw	1142
bone marrow tests	32
chemotherapy	514
diagnostic procedures	32
doctor visit	1264
hormone therapy	80
hospital care	270
inpatient care	270
lab tests	3373
minimally invasive procedures	585
port flush	66

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	330
Female	458

**Ethnicity**
Non-Hispanic White	661
Black	99
Hispanic	0
Asian	0
Other	13
Native American	0

**Age**
From 65 to 74	349
From 75 to 84	279
85 and over	79
Less than 65	81

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2017

Hypertension	72
High Cholesterol	50
Stroke	6
Ischemic Heart Disease	41
Depression	20
Chronic Kidney Disease	36
Asthma	8
Osteoperosis	10
Atrial Fibrilation	15
Heart Failure	20
Chronic Obstructive Pulmonary Disease	22
Diabetes	32
Dementia	11
Cancer	58

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

biological response modifier (BRM) therapy	497
blood draw	1285
chemotherapy	497
doctor visit	1254
hormone therapy	46
hospital care	190
inpatient care	190
lab tests	3644
minimally invasive procedures	561
port flush	49
thyroid function tests	231

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	325
Female	426

**Ethnicity**
Non-Hispanic White	634
Black	98
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	313
From 75 to 84	280
85 and over	84
Less than 65	74

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2018

Hypertension	72
High Cholesterol	57
Stroke	6
Ischemic Heart Disease	42
Depression	18
Chronic Kidney Disease	38
Asthma	6
Osteoperosis	9
Atrial Fibrilation	13
Heart Failure	21
Chronic Obstructive Pulmonary Disease	19
Diabetes	32
Dementia	11
Cancer	56

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

biological response modifier (BRM) therapy	558
blood draw	1302
chemotherapy	558
doctor visit	1241
hormone therapy	45
hospital care	195
inpatient care	195
lab tests	3786
minimally invasive procedures	612
port flush	35
thyroid function tests	411

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	283
Female	336

**Ethnicity**
Non-Hispanic White	544
Black	56
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	257
From 75 to 84	234
85 and over	68
Less than 65	60

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2019

Hypertension	71
High Cholesterol	59
Stroke	5
Ischemic Heart Disease	45
Depression	17
Chronic Kidney Disease	38
Asthma	7
Osteoperosis	12
Atrial Fibrilation	16
Heart Failure	23
Chronic Obstructive Pulmonary Disease	19
Diabetes	31
Dementia	11
Cancer	52

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

biological response modifier (BRM) therapy	465
blood draw	1096
chemotherapy	465
doctor visit	1091
hormone therapy	50
hospital care	45
inpatient care	45
lab tests	2961
minimally invasive procedures	556
port flush	44
thyroid function tests	310

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	231
Female	272

**Ethnicity**
Non-Hispanic White	440
Black	46
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	210
From 75 to 84	199
85 and over	54
Less than 65	40

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2020

Hypertension	69
High Cholesterol	55
Stroke	6
Ischemic Heart Disease	45
Depression	21
Chronic Kidney Disease	36
Asthma	4
Osteoperosis	10
Atrial Fibrilation	12
Heart Failure	20
Chronic Obstructive Pulmonary Disease	17
Diabetes	27
Dementia	10
Cancer	54

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

biological response modifier (BRM) therapy	377
blood draw	878
chemotherapy	377
doctor visit	796
hormone therapy	28
hospital care	131
inpatient care	131
lab tests	2338
minimally invasive procedures	433
port flush	29
thyroid function tests	134
urologic procedures	27

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	225
Female	263

**Ethnicity**
Non-Hispanic White	416
Black	56
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	219
From 75 to 84	185
85 and over	51
Less than 65	33

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2021

Hypertension	72
High Cholesterol	60
Stroke	4
Ischemic Heart Disease	46
Depression	22
Chronic Kidney Disease	40
Asthma	7
Osteoperosis	12
Atrial Fibrilation	15
Heart Failure	26
Chronic Obstructive Pulmonary Disease	17
Diabetes	32
Dementia	13
Cancer	52

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

biological response modifier (BRM) therapy	215
blood draw	595
chemotherapy	215
doctor visit	546
hospital care	52
inpatient care	52
lab tests	1648
minimally invasive procedures	288
port flush	14
thyroid function tests	119

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	175
Female	257

**Ethnicity**
Non-Hispanic White	367
Black	52
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	170
From 75 to 84	174
85 and over	45
Less than 65	43

Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD in 2022

Hypertension	75
High Cholesterol	72
Stroke	9
Ischemic Heart Disease	38
Depression	23
Chronic Kidney Disease	30
Asthma	9
Osteoperosis	17
Atrial Fibrilation	23
Heart Failure	19
Chronic Obstructive Pulmonary Disease	21
Diabetes	33
Dementia	8
Cancer	55

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Michael W. Meshad, MD for Medicare patients.

The highest averages for the top procedures that Dr. Michael W. Meshad, MD treated as a medical oncologist in Daphne, AL were lab tests, blood draw, minimally invasive procedures and chemotherapy.

aspiration	17
biological response modifier (BRM) therapy	498
blood draw	1142
bone marrow tests	34
chemotherapy	498
diagnostic procedures	34
doctor visit	1233
hormone therapy	77
hospital care	204
inpatient care	204
lab tests	3474
minimally invasive procedures	565
preventive care	15
thyroid function tests	241
urologic procedures	27
vaccines	15

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Michael W. Meshad, MD.

**Gender**
Male	274
Female	387

**Ethnicity**
Black / African American	87
Asian / Pacific Islander	0
Non-Hispanic White	557
Native American / Alaskan Native	0
Hispanic	0
Other	1

**Age**
75 to 84	234
85 and over	72
Less than 65	65
65 to 74	288

Average of Total of Conditions of Medicare patients treated by Dr. Michael W. Meshad, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Michael W. Meshad, MD treated were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension	64
High Cholesterol	50
Stroke	5
Ischemic Heart Disease	37
Depression	16
Chronic Kidney Disease	30
Asthma	8
Osteoporosis	9
Heart Failure	19
Chronic Obstructive Pulmonary Disease	16
Diabetes	27
Atrial Fibrillation	13
Dementia	9
Cancer	50

Education & Training

Dr. Michael W. Meshad, MD graduated from University of Alabama at Birmingham School of Medicine in 1972. He completed residency at University of South Alabama Affiliated Hospitals. He is certified by the American Board of Internal Medicine Medical Oncology and has a state license in Alabama.

Medical School: University of Alabama at Birmingham School of Medicine (1972)

Residency: University of South Alabama Affiliated Hospitals

Board Certification: American Board of Internal Medicine Medical Oncology

Licensed In: Alabama

Affiliations & Hospitals

Dr. Michael W. Meshad, MD is associated with these hospitals and organizations:

Infirmary Health

Baldwin Health

Mobile Infirmary

SOUTHERN CANCER CENTER PC

Ratings & Reviews

Dr. Michael W. Meshad, MD does not have any reviews yet, be the first to leave a review of Dr. Michael W. Meshad, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Michael W. Meshad, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Lilly USA, LLC	$20,693 RETEVMO $84	VERZENIO $78	CYRAMZA $56	ALIMTA $25	PORTRAZZA $11	Other $20,439
Novartis Pharmaceuticals Corporation	$3,420 KISQALI $1,417	TASIGNA $523	PROMACTA $256	TAFINLAR $210	FEMARA $128	Other $887
E.R. Squibb & Sons, L.L.C.	$1,546 OPDIVO $859	YERVOY $161	SPRYCEL $125	ERBITUX $55	Inrebic $48	Other $298
Amgen Inc.	$1,272 XGEVA $524	Vectibix $334	Kyprolis $136	LUMAKRAS $97	Nplate $58	Other $122
Genentech USA, Inc.	$1,226 TECENTRIQ $323	TARCEVA $142	Venclexta $110	Gazyva $99	Kadcyla $86	Other $467
Other	$12,130 KEYTRUDA $743	XTANDI $688	Lenvima $376	LYNPARZA $363	Venclexta $355	Other $9,604

**Types of Payments**
Consulting Fee	$20,423
Food and Beverage	$17,436
Travel and Lodging	$1,508
Education	$921

Research Payments

Dr. Michael W. Meshad, MD has received 1072 research payments totaling $4,139,131.

Ownership and Interest Payments

This table describes ownership payments received by Dr. Michael W. Meshad, MD.

RT Oncology Services Corporation

2015

$12,500.00

Physician Covered Recipient

STOCK OWNERSHIP

Biography

Dr. Michael Meshad specializes in adult hematology, adult oncology, and medical oncology and practices in Daphne, AL and Mobile, AL. Dr. Meshad studied medicine at the University of Alabama at Birmingham School of Medicine. For his residency, Dr. Meshad trained at a hospital affiliated with the University of South Alabama. His professional affiliations include Infirmary Health and Baldwin Health.